Live Breaking News & Updates on Ibio Inc

Stay updated with breaking news from Ibio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

iBio (NYSEAMERICAN:IBIO) Upgraded to "Hold" by Zacks Investment Research

Zacks Investment Research upgraded shares of iBio (NYSEAMERICAN:IBIO – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch […] ....

United States , Sbio Company Profile Get Rating , Qube Research Technologies Ltd , Goldman Sachs Group Inc , Zacks Investment Research , Bio Inc , Ibio Inc , Biopharma Inc , Wells Fargo Company , Barclays Plc , Millennium Management , Get Rating , Sachs Group , Qube Research , Technologies Ltd , Sbio Company Profile , Nyseamerican Ibio ,

iBio (NYSEAMERICAN:IBIO) Upgraded to "Hold" by Zacks Investment Research

iBio (NYSEAMERICAN:IBIO) Upgraded to "Hold" by Zacks Investment Research
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

United States , Thomson Reuter , Schonfeld Strategic Advisors , Zacks Investment Research , Sbio Company Profile , Bio Inc , Ibio Inc , Biopharma Inc , Cubist Systematic Strategies , Citigroup Inc , Strategic Advisors , Systematic Strategies , Bio Company ,